Search research articles
Contact Us
Filters
Showing results (31-40 of 38) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 38 results.
Bone Marrow Transplantation
|
March 30, 2021
High rate of invasive fungal infections after non-T cell depleted haploidentical allo-HSCT even under antifungal prophylaxis
Ming-Yu Lien, Su-Peng Yeh, Jyh-Pyng Gau, et al.
Journal of Virology
|
January 31, 2024
BGLF4 kinase regulates the formation of the EBV cytoplasmic assembly compartment and the recruitment of cellular IQGAP1 for virion release
Yu-Ching Dai, Szu-Yun Yeh, Yi-Ying Cheng, et al.
International Journal of Hematology
|
February 26, 2025
Risk of ankylosing spondylitis in long-term follow-up of hematopoietic stem cell donors: impact of HLA-B27 status and donation type
Sung-Chao Chu, Chia-Jung Hsieh, Shang-Hsien Yang, et al.
Nature Communications
|
January 21, 2025
N-Cadherin promotes cardiac regeneration by potentiating pro-mitotic β-Catenin signaling in cardiomyocytes
Yi-Wei Tsai, Yi-Shuan Tseng, Yu-Shuo Wu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
October 29, 2025
Consensus of the Hematology Society of Taiwan on the management of paroxysmal nocturnal hemoglobinuria (PNH)
Wei-Han Huang, Hsin-An Hou, Wen-Chien Chou, et al.
Experimental Hematology & Oncology
|
October 16, 2023
Chinese expert consensus on Bruton tyrosine kinase inhibitors in the treatment of B-cell malignancies
Yuqin Song, Shang-Ju Wu, Zhixiang Shen, et al.
The New England Journal of Medicine
|
March 13, 2024
Oral Iptacopan Monotherapy in Paroxysmal Nocturnal Hemoglobinuria
Régis Peffault de Latour, Alexander Röth, Austin G Kulasekararaj, et al.
The Lancet. Haematology
|
May 30, 2025
Oral iptacopan monotherapy in paroxysmal nocturnal haemoglobinuria: final 48-week results from the open-label, randomised, phase 3 APPLY-PNH trial in anti-C5-treated patients and the open-label, single-arm, phase 3 APPOINT-PNH trial in patients previously untreated with complement inhibitors
Antonio M Risitano, Austin G Kulasekararaj, Phillip Scheinberg, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 38) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 38 results.
Bone Marrow Transplantation
|
March 30, 2021
High rate of invasive fungal infections after non-T cell depleted haploidentical allo-HSCT even under antifungal prophylaxis
Ming-Yu Lien, Su-Peng Yeh, Jyh-Pyng Gau, et al.
Journal of Virology
|
January 31, 2024
BGLF4 kinase regulates the formation of the EBV cytoplasmic assembly compartment and the recruitment of cellular IQGAP1 for virion release
Yu-Ching Dai, Szu-Yun Yeh, Yi-Ying Cheng, et al.
International Journal of Hematology
|
February 26, 2025
Risk of ankylosing spondylitis in long-term follow-up of hematopoietic stem cell donors: impact of HLA-B27 status and donation type
Sung-Chao Chu, Chia-Jung Hsieh, Shang-Hsien Yang, et al.
Nature Communications
|
January 21, 2025
N-Cadherin promotes cardiac regeneration by potentiating pro-mitotic β-Catenin signaling in cardiomyocytes
Yi-Wei Tsai, Yi-Shuan Tseng, Yu-Shuo Wu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
October 29, 2025
Consensus of the Hematology Society of Taiwan on the management of paroxysmal nocturnal hemoglobinuria (PNH)
Wei-Han Huang, Hsin-An Hou, Wen-Chien Chou, et al.
Experimental Hematology & Oncology
|
October 16, 2023
Chinese expert consensus on Bruton tyrosine kinase inhibitors in the treatment of B-cell malignancies
Yuqin Song, Shang-Ju Wu, Zhixiang Shen, et al.
The New England Journal of Medicine
|
March 13, 2024
Oral Iptacopan Monotherapy in Paroxysmal Nocturnal Hemoglobinuria
Régis Peffault de Latour, Alexander Röth, Austin G Kulasekararaj, et al.
The Lancet. Haematology
|
May 30, 2025
Oral iptacopan monotherapy in paroxysmal nocturnal haemoglobinuria: final 48-week results from the open-label, randomised, phase 3 APPLY-PNH trial in anti-C5-treated patients and the open-label, single-arm, phase 3 APPOINT-PNH trial in patients previously untreated with complement inhibitors
Antonio M Risitano, Austin G Kulasekararaj, Phillip Scheinberg, et al.
Page
of 4